Nitin B. Chandurkar

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel.

Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel.

Journal: Open heart

Published: November 22, 2024

Inflammation, infection, and cardiovascular risk.

Inflammation, infection, and cardiovascular risk.

Journal: Lancet (London, England)

Published: March 17, 2023

Risk vs Benefits of Thiazides in Clinical Use: Need for a Holistic Approach.

Risk vs Benefits of Thiazides in Clinical Use: Need for a Holistic Approach.

Journal: The American journal of medicine

Published: October 11, 2021

Congestive heart failure: more common as well as an important cardiovascular outcome.

Congestive heart failure: more common as well as an important cardiovascular outcome.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: December 28, 2016

Statin therapy now more common than steroids in clinical practice.

Statin therapy now more common than steroids in clinical practice.

Journal: Annals of the rheumatic diseases

Published: November 22, 2016

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

Journal: The New England journal of medicine

Published: November 03, 2016

Reply: Efficacy of Low-Dose Chlorthalidone Versus Hydrochlorothiazide Remains Ambiguous.

Reply: Efficacy of Low-Dose Chlorthalidone Versus Hydrochlorothiazide Remains Ambiguous.

Journal: Journal of the American College of Cardiology

Published: May 02, 2016

Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.

Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.

Journal: Journal of the American College of Cardiology

Published: October 01, 2015

Drug approvals in India.

Drug approvals in India.

Journal: The lancet. Diabetes & endocrinology

Published: September 25, 2015

Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine: a randomized, double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia.

Efficacy and safety of fixed dose combination of atorvastatin and hydroxychloroquine: a randomized, double-blind comparison with atorvastatin alone among Indian patients with dyslipidemia.

Journal: Current medical research and opinion

Published: September 16, 2015

Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study.

Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study.

Journal: Malaria research and treatment

Published: July 04, 2015

Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study.

Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: August 16, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026